Clinical Trial Update: Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for inhaled lipid cisplatin in pulmonary relapse osteosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma
• Pulmonary Metastasis of Osteosarcoma

Drugs mentioned

• inhaled lipid cisplatin (lipid cisplatin)

Snippet

Sponsor: Eleison Pharmaceuticals LLC. | Conditions: Pulmonary Relapse of Osteosarcoma | Phase 2 | Status: COMPLETED